After undergoing surgery for an enlarged prostate and being diagnosed with cancer in February, King Charles has returned to public-facing duties.
His Majesty, along with Queen Camilla, attended the University College Hospital Macmillan Cancer Centre in London, where they sat with patients and spoke to staff about the importance of early detection and prevention, and their use of innovative technology to do so.
King Charles reported that he was feeling “alright”, and even disclosed to a patient that he was undergoing a round of treatment himself later that day.
This visit marks his first day as the new Patron of Cancer Research UK. While this position is a continuation of his role as Patron of Macmillan Cancer Support, King Charles’ new role is one passed on by his late mother, Queen Elizabeth.
The visit follows a statement released by Buckingham Palace, announcing the King’s return to public-facing duties along with his summer schedule of events.
“To help mark this milestone, The King and Queen will make a joint visit to a cancer treatment centre next Tuesday, where they will meet medical specialists and patients.
“This visit will be the first in a number of external engagements His Majesty will undertake in the weeks ahead.” the statement read.
“In addition, The King and Queen will host Their Majesties The Emperor and Empress of Japan for a State Visit in June, at the request of HM Government.
“As the first anniversary of The Coronation approaches, Their Majesties remain deeply grateful for the many kindnesses and good wishes they have received from around the world throughout the joys and challenges of the past year.”
This comes after King Charles first revealed he had been diagnosed with cancer on February 6, sharing the cancer was discovered during his recent surgery for a benign prostate enlargement. The type of cancer has not been disclosed.
The King’s willingness to share his diagnosis with the public is unsurprising as it comes not long after his recent transparency over his scheduled surgery for an enlarged prostate.
In the full statement issued by the palace, they confirmed the reasoning behind this decision was to “prevent speculation” and to raise awareness and “public understanding” for those impacted by cancer.
